Market Cap 7.56B
Revenue (ttm) 642.82M
Net Income (ttm) -43.54M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6.77%
Debt to Equity Ratio 0.00
Volume 1,969,700
Avg Vol 3,233,562
Day's Range N/A - N/A
Shares Out 130.29M
Stochastic %K 69%
Beta 2.03
Analysts Sell
Price Target $48.57

Company Profile

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and singl...

Industry: Health Information Services
Sector: Healthcare
Phone: 925 401 7300
Address:
6230 Stoneridge Mall Road, Pleasanton, United States
MaverikIT
MaverikIT Aug. 17 at 7:53 PM
@cynicaloptimist @Jblack500 @WAJeff let's $TWST and $PLSE ing again $NTRA $TXG ...
1 · Reply
Zephix
Zephix Aug. 13 at 9:32 PM
0 · Reply
LongStoryShortsky
LongStoryShortsky Aug. 12 at 9:40 PM
$TXG next stop 50
1 · Reply
strassburg
strassburg Aug. 11 at 11:06 PM
$TXG In at 32. Man, it’s hard not to sell right now, but i love this company long. May sell half and secure some profit. What u guys think?
2 · Reply
Pika_Capital
Pika_Capital Aug. 11 at 8:21 PM
$SEER $CDXS $QTRX $TXG Lmao entire life sciences landscape is a total joke. Tons of garbage is trading at 90% discount. Some of these down the road will recover but most of them will disappear
1 · Reply
Lowkeyoptions
Lowkeyoptions Aug. 10 at 7:29 PM
$TXG $TENX just wait for the move lol. You have the three legged horse not 4
0 · Reply
manojaggarwal
manojaggarwal Aug. 10 at 7:28 PM
$TXG dude I thought I had this in my portfolio but I have $TENX instead 😢 I done messed up 😭
1 · Reply
IN0V8
IN0V8 Aug. 10 at 5:18 PM
$TXG Canaccord Genuity raises target price to $60 from $50
0 · Reply
WAJeff
WAJeff Aug. 10 at 3:38 PM
$TXG 7/1 39s sold at 56
0 · Reply
WAJeff
WAJeff Aug. 10 at 2:03 PM
$TXG Quite the year here
2 · Reply
Latest News on TXG
10x Genomics price target raised to $65 from $50 at Stephens

2026-08-17T09:25:26.000Z - 2 days ago

10x Genomics price target raised to $65 from $50 at Stephens


10x Genomics price target raised to $50 from $25 at Stifel

2026-08-07T13:05:27.000Z - 11 days ago

10x Genomics price target raised to $50 from $25 at Stifel


10x Genomics price target raised to $50 from $45 at Citi

2026-08-07T11:01:03.000Z - 11 days ago

10x Genomics price target raised to $50 from $45 at Citi


10x Genomics Earnings Call Transcript: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

10x Genomics Earnings Call Transcript: Q2 2026


10x Genomics Earnings release: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

10x Genomics Earnings release: Q2 2026


10x Genomics Quarterly report: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

10x Genomics Quarterly report: Q2 2026


10x Genomics reports Q2 EPS (14c), consensus (2c)

2026-08-06T20:18:44.000Z - 12 days ago

10x Genomics reports Q2 EPS (14c), consensus (2c)


10x Genomics Reports Second Quarter 2026 Financial Results

Aug 6, 2026, 4:02 PM EDT - 12 days ago

10x Genomics Reports Second Quarter 2026 Financial Results


10x Genomics price target raised to $40 from $23 at Leerink

2026-07-17T12:45:11.000Z - 4 weeks ago

10x Genomics price target raised to $40 from $23 at Leerink


10x Genomics price target raised to $47 from $25 at TD Cowen

2026-07-15T12:46:15.000Z - 4 weeks ago

10x Genomics price target raised to $47 from $25 at TD Cowen


10x Genomics price target raised to $50 from $32 at Canaccord

2026-07-14T11:00:55.000Z - 5 weeks ago

10x Genomics price target raised to $50 from $32 at Canaccord


10x Genomics Transcript: Transcript

Jul 8, 2026, 3:07 PM EDT - 5 weeks ago

10x Genomics Transcript: Transcript


10x Genomics price target raised to $45 from $24 at Citi

2026-07-08T10:45:32.000Z - 6 weeks ago

10x Genomics price target raised to $45 from $24 at Citi


10x Genomics price target raised to $40 from $30 at Barclays

2026-06-24T08:50:19.000Z - 2 months ago

10x Genomics price target raised to $40 from $30 at Barclays


Torex Gold Announces Results of Its 2026 Meeting of Shareholders

Jun 17, 2026, 5:00 PM EDT - 2 months ago

Torex Gold Announces Results of Its 2026 Meeting of Shareholders


10x Genomics acquires Proteintech Genomics

2026-06-09T13:11:53.000Z - 2 months ago

10x Genomics acquires Proteintech Genomics


10x Genomics Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

10x Genomics Earnings Call Transcript: Q1 2026


10x Genomics Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

10x Genomics Earnings release: Q1 2026


10x Genomics Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

10x Genomics Quarterly report: Q1 2026


10x Genomics Reports First Quarter 2026 Financial Results

May 7, 2026, 4:05 PM EDT - 3 months ago

10x Genomics Reports First Quarter 2026 Financial Results


10x Genomics Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

10x Genomics Proxy statement: Proxy filing


10x Genomics Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

10x Genomics Proxy statement: Proxy filing


10x Genomics Slides: Corporate presentation

Apr 17, 2026, 7:00 AM EDT - 4 months ago

10x Genomics Slides: Corporate presentation


10x Genomics Earnings Call Transcript: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

10x Genomics Earnings Call Transcript: Q4 2025


10x Genomics Annual report: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

10x Genomics Annual report: Q4 2025


10x Genomics Earnings release: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

10x Genomics Earnings release: Q4 2025


10x Genomics Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 11:15 AM EST - 7 months ago

10x Genomics Slides: 44th Annual J.P. Morgan Healthcare Conference


10x Genomics Transcript: Wolfe Research Healthcare Conference 2025

Nov 18, 2025, 11:20 AM EST - 9 months ago

10x Genomics Transcript: Wolfe Research Healthcare Conference 2025


10x Genomics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

10x Genomics Earnings Call Transcript: Q3 2025


10x Genomics Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

10x Genomics Quarterly report: Q3 2025


10x Genomics Earnings release: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

10x Genomics Earnings release: Q3 2025


10x Genomics Reports Third Quarter 2025 Financial Results

Nov 6, 2025, 4:05 PM EST - 10 months ago

10x Genomics Reports Third Quarter 2025 Financial Results


10x Genomics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

10x Genomics Earnings Call Transcript: Q2 2025


10x Genomics Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

10x Genomics Quarterly report: Q2 2025


10x Genomics Earnings release: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

10x Genomics Earnings release: Q2 2025


10x Genomics Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:05 PM EDT - 1 year ago

10x Genomics Reports Second Quarter 2025 Financial Results


10x Genomics to Acquire Scale Biosciences

Aug 7, 2025, 4:04 PM EDT - 1 year ago

10x Genomics to Acquire Scale Biosciences


10x Genomics Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

10x Genomics Earnings Call Transcript: Q1 2025


10x Genomics Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

10x Genomics Quarterly report: Q1 2025


10x Genomics Earnings release: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

10x Genomics Earnings release: Q1 2025


10x Genomics Reports First Quarter 2025 Financial Results

May 8, 2025, 4:05 PM EDT - 1 year ago

10x Genomics Reports First Quarter 2025 Financial Results


10x Genomics Proxy statement: Proxy Filing

Apr 15, 2025, 8:00 AM EDT - 1 year ago

10x Genomics Proxy statement: Proxy Filing


10x Genomics Proxy statement: Proxy Filing

Apr 14, 2025, 8:00 AM EDT - 1 year ago

10x Genomics Proxy statement: Proxy Filing


10x Genomics Earnings Call Transcript: Q4 2024

Feb 12, 2025, 4:30 PM EST - 1 year ago

10x Genomics Earnings Call Transcript: Q4 2024


10x Genomics Annual report: Q4 2024

Feb 12, 2025, 4:30 PM EST - 1 year ago

10x Genomics Annual report: Q4 2024


10x Genomics Earnings release: Q4 2024

Feb 12, 2025, 4:30 PM EST - 1 year ago

10x Genomics Earnings release: Q4 2024


MaverikIT
MaverikIT Aug. 17 at 7:53 PM
@cynicaloptimist @Jblack500 @WAJeff let's $TWST and $PLSE ing again $NTRA $TXG ...
1 · Reply
Zephix
Zephix Aug. 13 at 9:32 PM
0 · Reply
LongStoryShortsky
LongStoryShortsky Aug. 12 at 9:40 PM
$TXG next stop 50
1 · Reply
strassburg
strassburg Aug. 11 at 11:06 PM
$TXG In at 32. Man, it’s hard not to sell right now, but i love this company long. May sell half and secure some profit. What u guys think?
2 · Reply
Pika_Capital
Pika_Capital Aug. 11 at 8:21 PM
$SEER $CDXS $QTRX $TXG Lmao entire life sciences landscape is a total joke. Tons of garbage is trading at 90% discount. Some of these down the road will recover but most of them will disappear
1 · Reply
Lowkeyoptions
Lowkeyoptions Aug. 10 at 7:29 PM
$TXG $TENX just wait for the move lol. You have the three legged horse not 4
0 · Reply
manojaggarwal
manojaggarwal Aug. 10 at 7:28 PM
$TXG dude I thought I had this in my portfolio but I have $TENX instead 😢 I done messed up 😭
1 · Reply
IN0V8
IN0V8 Aug. 10 at 5:18 PM
$TXG Canaccord Genuity raises target price to $60 from $50
0 · Reply
WAJeff
WAJeff Aug. 10 at 3:38 PM
$TXG 7/1 39s sold at 56
0 · Reply
WAJeff
WAJeff Aug. 10 at 2:03 PM
$TXG Quite the year here
2 · Reply
WAJeff
WAJeff Aug. 8 at 5:02 AM
$TXG $52.22 52 week high
0 · Reply
CNMI670
CNMI670 Aug. 8 at 4:47 AM
ACOG Alpha Cognition - Opaleye Mgmt buys ahead of earnings on Aug 13. 52wk high momo: $HALO $RCEL $IOVA $TXG $OABI : IVA!
0 · Reply
financials_please
financials_please Aug. 8 at 1:45 AM
$TXG some updates on TXG's competition in spatial bio: - Vizgen is a secondary competitor and raised money in January 2026 to scale out manufacturing and expand. Atera is revealed in April 2026 and Vizgen announces layoffs at the end of May 2026, a narrowing of focus to neuroscience applications, and outsourcing manufacturing (the very thing they raised money for). My take is that their orderbool vaporized when their customers saw Atera. - Bruker Spatial Bio just lost their CSO, Joe Beechem, that came in from the Nanostring acquisition. He was their CSO as well and is considered to be the face of GeoMx/CosMx development, as well as a source of credibility with their academic customers. He apparently left in July to start his own venture, currently in stealth mode. This implies that Bruker has no material response, and this stealth venture would take at least 4-5 years to ship something commercially. He is also like 67 years old, so he might not be doing this for much longer.
1 · Reply
Mduro
Mduro Aug. 7 at 8:19 PM
0 · Reply
AVGOInsights
AVGOInsights Aug. 7 at 3:28 PM
$TXG after THAT ER, down 3.5%, to be up 5.5%…who knew?
1 · Reply
financials_please
financials_please Aug. 7 at 3:16 PM
$TXG someone go find BioGem, looks like their short might be doing interesting things lol
0 · Reply
EarningsInsider
EarningsInsider Aug. 7 at 1:45 PM
https://www.marketbeat.com/earnings/reports/2026-8-6-torex-gold-resources-inc-txgto-stock/ $TXG Torex Gold Resources Earnings Transcript
1 · Reply
Inajiffy
Inajiffy Aug. 7 at 1:40 PM
$TXG cashed my nearly 50% from 2 June. good luck holders.
1 · Reply
DonCorleone77
DonCorleone77 Aug. 7 at 1:16 AM
$CABO $MRVI $RMD $TXG $DBX AFTER-HOURS MOVERS: Currently Higher After Earnings: Doximity (DOCS) up 73.8% Atlassian (TEAM) up 32.9% Figs (FIGS) up 23.7% QuinStreet (QNST) up 27.9% Cloudflare (NET) up 16.2% Twilio (TWLO) up 17.0% Natera (NTRA) up 15.4% Akamai (AKAM) up 12.1% Onto Innovation (ONTO) up 13.0% Airbnb (ABNB) up 7.8% Instacart (CART) up 9.9% Currently Also Higher: DoubleVerify (DV) up 13.2% after Nielsen agreed to acquire the company in an all-cash transaction valued at roughly $2.15B Currently Lower After Earnings: Trade Desk (TTD) down 24.3% QuidelOrtho (QDEL) down 23.1% Xponential Fitness (XPOF) down 12.7% Cable One (CABO) down 9.5% Maravai Lifesciences (MRVI) down 7.2% ResMed (RMD) down 5.9% 10x Genomics (TXG) down 3.5%. Dropbox (DBX) down 6.5% Post Holdings (POST) down 2.6%
0 · Reply
buyitall888
buyitall888 Aug. 6 at 8:20 PM
$TXG omg terrible er
3 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 6 at 8:11 PM
$TXG Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.14 down -150.00% YoY • Reported revenue of $151.04M down -12.65% YoY • 10x Genomics is raising its full year 2026 revenue guidance and now expects revenue in the range of $610 million to $630 million, representing 2% to 5% growth over 2025.
0 · Reply
Estimize
Estimize Aug. 6 at 8:00 PM
Wall St is expecting -0.25 EPS for $TXG Q3 [Reporting 11/04 AMC] http://www.estimize.com/intro/txg?chart=historical&metric_name=eps&utm_con
0 · Reply